Skip to content

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

Five cancers seen in vicriviroc study `not causally related`, study continues

CROI: Early vs delayed Trizivir in TB/HIV coinfected - no difference in rate of IRIS

CROI: More data on role of antiretrovirals, interventions, HCV, in cardiovascular disease risk

HAART reduces AIDS events even when treatment response is poor

Simultaneous HIV therapy and chemotherapy for lymphoma effective and safe

CROI: Studies begin to identify genes linked to metabolic and body fat changes

CROI: Persistent brain impairment despite HIV treatment linked to severity of prior dementia